A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

INTRODUCTION: Various multigene predictors of breast cancer clinical outcome have been commercialized, but proved to be prognostic only for hormone receptor (HR) subsets overexpressing estrogen or progesterone receptors. Hormone receptor negative (HRneg) breast cancers, particularly those lacking HE...

Descripción completa

Detalles Bibliográficos
Autores principales: Yau, Christina, Esserman, Laura, Moore, Dan H, Waldman, Fred, Sninsky, John, Benz, Christopher C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096978/
https://www.ncbi.nlm.nih.gov/pubmed/20946665
http://dx.doi.org/10.1186/bcr2753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096978/
https://www.ncbi.nlm.nih.gov/pubmed/20946665
http://dx.doi.org/10.1186/bcr2753

Ejemplares similares